Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioural sensitization

Babbini, 1972, Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment, Br. J. Pharmacol., 46, 213, 10.1111/j.1476-5381.1972.tb06866.x

Barr, 1985, Place conditioning with morphine and phencyclidine: dose dependent effects, Life Sci., 36, 363, 10.1016/0024-3205(85)90122-5

Bespalov, 1994, Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine, Eur. J. Pharmacol., 264, 233, 10.1016/0014-2999(94)00462-5

Bischoff, 1992, Competitive and non-competitive NMDA receptor antagonists in spatial learning tasks, Eur. J. Pharmacol., 213, 269, 10.1016/0014-2999(92)90691-V

Bozarth, 1987, Neuroanatomical boundaries of the reward-relevant opiate-receptor field in the ventral tegmental area as mapped by the conditioned place preference method in rats, Brain Res., 414, 77, 10.1016/0006-8993(87)91327-8

Bubser, 1995, Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats, J. Neural Transm. [Gen. Sect.], 101, 115, 10.1007/BF01271550

Cador, 1995, Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine, Neuroscience, 65, 385, 10.1016/0306-4522(94)00524-9

Carlezon, 1995, MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation, Synapse, 20, 1, 10.1002/syn.890200102

Carr, 1989, Conditioned place preference as a measure of drug reward, 264

Cervo, 1995, Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference, Brain Res., 673, 242, 10.1016/0006-8993(94)01420-M

Colpaert, 1990, Amnesic trace locked into the benzodiazepine state of memory, Psychopharmacology, 102, 28, 10.1007/BF02245740

Corbett, 1989, Possible abuse potential of the NMDA antagonist MK-801, Behav. Brain Res., 34, 239, 10.1016/S0166-4328(89)80105-6

Cory-Slechta, 1994, The impact of NMDA receptor antagonists on learning and memory functions, Psychopharmacol. Bull., 30, 601

Cox, 1994, MK801 impairs acquisition and expression of conditioned responses in the rabbit nictating membrane preparation, Psychobiology, 22, 156, 10.3758/BF03327094

Cox, 1994, The NMDA receptor antagonist MK-801 blocks acquisition and extinction of conditioned hypoalgesic responses in the rat, Quart. J. Exp. Psychol., 47B, 187

Dall Olio, 1992, Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat, Psychopharmacology, 107, 591, 10.1007/BF02245275

Herberg, 1989, The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward, Psychopharmacology, 99, 87, 10.1007/BF00634458

Hoffman, 1989, The use of place conditioning in studying the neuropharmacology of drug reinforcement, Brain Res. Bull., 23, 373, 10.1016/0361-9230(89)90224-4

Hoffman, 1994, The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats, Pharmacol. Biochem. Behav., 47, 907, 10.1016/0091-3057(94)90295-X

Jackson, 1992, NMDA antagonists make learning and recall state-dependent, Behav. Pharmacol., 3, 415, 10.1097/00008877-199208000-00018

Jeziorski, 1994, MK-801 prevents the development of behavioral sensitization during repeated morphine administration, Synapse, 16, 137, 10.1002/syn.890160207

Kalivas, 1995, Can EAA transmission play a ubiquitous role in drug-induced neural plasticity?, Behav. Pharmacol., 6, 452, 10.1097/00008877-199508000-00006

Kalivas, 1993, Involvement of N-methyl-d-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine, J. Pharmacol. Exp. Ther., 267, 486

Kalivas, 1991, Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity, Brain Res. Rev., 16, 223, 10.1016/0165-0173(91)90007-U

Karcz-Kubicha, 1995, Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test, Eur. J. Pharmacol., 279, 171, 10.1016/0014-2999(95)00153-C

Karler, 1989, Blockade of ‘reverse tolerance’ to cocaine and amphetamine by MK-801, Life Sci., 45, 599, 10.1016/0024-3205(89)90045-3

Karler, 1994, Cocaine behavioral sensitization and the excitatory amino acids, Psychopharmacology, 115, 305, 10.1007/BF02245070

Karler, 1991, DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552, 295, 10.1016/0006-8993(91)90095-D

Keseberg, 1995, Low-dose challenge by the NMDA receptor antagonist dizocilpine exacerbates the spatial learning deficit in ntorhinal cortex-lesioned rats, Behav. Brain Res., 67, 255, 10.1016/0166-4328(94)00156-A

Koob, 1992, Drugs of abuse: anatomy, pharmacology and function of reward pathways, Trends Pharmacol. Sci., 13, 177, 10.1016/0165-6147(92)90060-J

Layer, 1993, The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats, Pharmacol. Biochem. Behav., 44, 245, 10.1016/0091-3057(93)90306-E

Manallack, 1989, Subchronic administration of MK801 in the rat decreases cortical binding of [3H]D-AP5, Neuroscience, 30, 87, 10.1016/0306-4522(89)90355-2

Marek, 1991, Delayed application of MK-801 attenuates development of morphine tolerance in rats, Brain Res., 558, 163, 10.1016/0006-8993(91)90736-F

Morris, 1986, Selective impairment of learning and blockade of long-term potentiation by an N-methyl-d-aspartate antagonist, AP5, Nature, 319, 774, 10.1038/319774a0

Oles, 1990, Differential effects on the behavioural and anticonvulsant properties of MK-801 following repeated administration in the mouse, Br. J. Pharmacol., 99, 286P

Papp, 1994, Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats, Pol. J. Pharmacol., 46, 79

Perugini, 1994, Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine, J. Pharmacol. Exp. Ther., 270, 690

Phillips, 1987, Anatomical and neurochemical substrates of drug reward determined by the conditioned place preference technique, 275

Spyraki, 1982, Dopaminergic substrates of amphetamine-induced place preference conditioning, Brain Res., 253, 185, 10.1016/0006-8993(82)90685-0

Spyraki, 1987, Intravenous cocaine-induced place preference: attenuation by haloperidol, Behav. Brain Res., 26, 57, 10.1016/0166-4328(87)90016-7

Sufka, 1994, Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain, Pain, 58, 355, 10.1016/0304-3959(94)90130-9

Swedberg, 1995, Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo [f] quinoxaline (NBQX), J. Pharmacol. Exp. Ther., 274, 1113

Tzschentke, 1995, N-Methyl-d-aspartic acidreceptor antagonists block morphine-induced conditioned place preference in rats, Neurosci. Lett., 193, 37, 10.1016/0304-3940(95)11662-G

Tzschentke, 1996, Procedural examination of behavioural sensitisation to morphine: lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross sensitisation between morphine and MK-801, Behav. Pharmacol., 7, 169, 10.1097/00008877-199603000-00008

Vasko, 1978, Tolerance development to the biphasic effects of morphine on locomotor activity and brain acetylcholine in the rat, J. Pharmacol. Exp. Ther., 207, 848

Wise, 1989, The brain and reward, 377

Wise, 1993, Psychomotor-stimulant sensitization: a unitary phenomenon?, Behav. Pharmacol., 4, 339, 10.1097/00008877-199308000-00007

Wolf, 1993, Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization, Brain Res., 613, 291, 10.1016/0006-8993(93)90913-8

Wolf, 1991, Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine, Brain Res., 562, 164, 10.1016/0006-8993(91)91202-C